About a week ago one guy said to buy at 140 (another shot him down). It then went to 151 and is now at 129. I'd like to buy some here but biotech has been so miserable for months buying now seems premature.
10% sales growth and 25% earnings growth in 2016 noted. Not much of a pop as a result of the presentation.
Said they stumbled last qtr, but correcting issues in people and products.
This isn't a high flyer or biotech stock yet it has been moving 5% a day a number of times in the last couple of weeks. What is the reason for that level of change?
I didn't know that CEO's issued ratings on stocks. Doesn't he have an analyst? I guess they've made a lot of layoffs and he needs to pick up a few new tasks.
2/6/15 downgrade to neutral with 115 target (price was 99 on 2/6/15)
1/20/16 started at outperform with 125 target (price was 90 on 1/20/16)
Does this sound like a company that has a clue?
It's common knowledge, but he keeps saying Merch is 40% cheaper than GILD drug. I guess facts don't get in the way of him talking all day.